Fig. 1From: Molecular subtyping improves prognostication of Stage 2 colorectal cancera Progression-free and (b) overall survival by consensus molecular subtype (CMS), and (c) progression-free and (d) overall survival by TNM stage. Kaplan-Meier survival curves with estimates and 95% confidence intervals for survival probabilities at 5 and 10 yearsBack to article page